• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

Recent Advances in the Application of 6-Amino-7-azaindole Dihydrochloride (CAS: 1170585-19-9) in Chemical Biology and Pharmaceutical Research

6-Amino-7-azaindole dihydrochloride (CAS: 1170585-19-9) has emerged as a pivotal scaffold in medicinal chemistry and chemical biology due to its unique structural properties and versatile pharmacological applications. Recent studies have highlighted its role as a privileged heterocyclic motif, particularly in the development of kinase inhibitors and other targeted therapies. This research briefing synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

One of the most significant breakthroughs involves the optimization of synthetic routes for 6-Amino-7-azaindole dihydrochloride, enabling higher yields and improved purity. Researchers have developed novel catalytic methods that reduce byproduct formation, which is critical for scaling up production for preclinical and clinical studies. These advancements are documented in recent publications in journals such as the Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In terms of biological activity, 6-Amino-7-azaindole dihydrochloride has shown promising results as a core structure in kinase inhibitors. Specifically, it has been utilized in the design of compounds targeting protein kinases involved in cancer and inflammatory diseases. Recent in vitro and in vivo studies demonstrate its efficacy in modulating kinase activity with high selectivity, reducing off-target effects. These findings are supported by crystallographic data revealing the binding modes of derivatives within kinase active sites.

Furthermore, the compound's potential extends beyond oncology. Recent preclinical studies have explored its application in neurodegenerative diseases, where it acts as a modulator of key signaling pathways implicated in neuroprotection. Researchers have also investigated its role in infectious diseases, particularly in the inhibition of viral polymerases. These diverse applications underscore the compound's versatility and its growing importance in drug discovery pipelines.

Looking ahead, the integration of computational chemistry and machine learning approaches is expected to accelerate the discovery of new 6-Amino-7-azaindole dihydrochloride derivatives with enhanced pharmacological profiles. Collaborative efforts between academia and industry are also paving the way for the translation of these findings into clinical candidates. This briefing concludes with a discussion of ongoing clinical trials and future research directions, emphasizing the compound's potential to address unmet medical needs across multiple therapeutic areas.

• 66358-23-4(Imidazo[1,2-a]pyridin-5-amine)
• 935466-69-6(4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine)
• 15992-83-3(1,8-Naphthyridin-2-amine)
• 26148-68-5(2-Amino-9H-pyrido2,3-bindole)
• 76587-31-0(Pyrido[2,3-d]pyrimidin-7-amine)
• 89418-03-1(7H-Pyrrolo[2,3-d]pyrimidin-6-amine)
• 37538-65-1(Pyrido[2,3-d]pyrimidin-4-amine)
• 145901-11-7(1H-Pyrrolo[2,3-b]pyridin-6-amine)
• 61634-73-9(1H-Indolo[2,3-b][1,8]naphthyridin-2-amine)
• 88243-00-9(1H-Pyrido[2,3-b]indolamine)